| scholarly article | Q13442814 |
| P2093 | author name string | F. M. Williams | |
| W. F. Flintoff | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | methotrexate | Q422232 |
| P304 | page(s) | 2987–2992 | |
| P577 | publication date | 1995-02-17 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake | |
| P478 | volume | 270 |
| Q36939355 | A Study of Single Nucleotide Polymorphisms of the SLC19A1/RFC1 Gene in Subjects with Autism Spectrum Disorder. |
| Q47828197 | A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function. |
| Q41045869 | A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate |
| Q48040147 | A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter w |
| Q54118067 | A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. |
| Q46036330 | Adaptive regulation of intestinal folate uptake: effect of dietary folate deficiency. |
| Q34144263 | Analysis of membrane topology of the human reduced folate carrier protein by hemagglutinin epitope insertion and scanning glycosylation insertion mutagenesis |
| Q42048612 | Analysis of the membrane topology for transmembrane domains 7-12 of the human reduced folate carrier by scanning cysteine accessibility methods |
| Q35155913 | Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity |
| Q42501623 | Association of deletions and translocation of the reduced folate carrier gene with profound loss of gene expression in methotrexate-resistant K562 human erythroleukemia cells |
| Q26998717 | Biology of the major facilitative folate transporters SLC19A1 and SLC46A1 |
| Q38354623 | Characterization of a cysteine-less human reduced folate carrier: localization of a substrate-binding domain by cysteine-scanning mutagenesis and cysteine accessibility methods |
| Q38291140 | Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line |
| Q34071693 | Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia |
| Q54044175 | Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake. |
| Q47950805 | Concentrating capacity of the human reduced folate carrier (hRFC1) in human ZR-75 breast cancer cell lines |
| Q41931152 | Confocal microscopy visualization of antifolate uptake by the reduced folate carrier in human leukaemic cells |
| Q40866234 | Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells |
| Q35946876 | Contribution of tumoral and host solute carriers to clinical drug response |
| Q41881973 | Cytoplasmic domains of the reduced folate carrier are essential for trafficking, but not function |
| Q40921250 | Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier |
| Q77393151 | Effects of the loss of capacity for N-glycosylation on the transport activity and cellular localization of the human reduced folate carrier |
| Q42771907 | Endocytosis of GPI-linked membrane folate receptor-alpha |
| Q28346424 | Functional interactions between arginine-133 and aspartate-88 in the human reduced folate carrier: evidence for a charge-pair association |
| Q73082739 | Human K562 transfectants expressing high levels of reduced folate carrier but exhibiting low transport activity |
| Q28590284 | Identification of a mouse thiamine transporter gene as a direct transcriptional target for p53 |
| Q43797545 | Intracellular trafficking/membrane targeting of human reduced folate carrier expressed in Xenopus oocytes |
| Q40947024 | Isolation and characterization of genomic sequences involved in the regulation of the human reduced folate carrier gene (RFC1). |
| Q34444820 | Localization of a substrate binding domain of the human reduced folate carrier to transmembrane domain 11 by radioaffinity labeling and cysteine-substituted accessibility methods |
| Q35173884 | Membrane transport of folates |
| Q54127315 | Methotrexate transport and resistance. |
| Q34087168 | Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells |
| Q34348434 | Molecular and cellular biology of the human reduced folate carrier |
| Q33747235 | Molecular and cellular correlates of methotrexate response in childhood acute lymphoblastic leukemia |
| Q30726340 | Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome |
| Q40891908 | Mutations in the reduced-folate carrier affect protein localization and stability |
| Q28207327 | Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase |
| Q36882214 | Organization of the murine reduced folate carrier gene and identification of variant splice forms |
| Q36862307 | Organization, structure and alternate splicing of the murine RFC-1 gene encoding a folate transporter |
| Q36803678 | Polymorphisms and methylation of the reduced folate carrier in osteosarcoma. |
| Q84466734 | Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations |
| Q33331479 | Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier |
| Q41100230 | Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines |
| Q73906467 | Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells |
| Q37274445 | Renal conservation of folates role of folate transport proteins |
| Q35567272 | Resistance to antifolates |
| Q24534987 | Restoration of high-level transport activity by human reduced folate carrier/ThTr1 thiamine transporter chimaeras: role of the transmembrane domain 6/7 linker region in reduced folate carrier function |
| Q40520881 | Restoration of transport activity by co-expression of human reduced folate carrier half-molecules in transport-impaired K562 cells: localization of a substrate binding domain to transmembrane domains 7-12. |
| Q37249995 | Role of lysine 411 in substrate carboxyl group binding to the human reduced folate carrier, as determined by site-directed mutagenesis and affinity inhibition |
| Q40687183 | Role of the E45K-reduced folate carrier gene mutation in methotrexate resistance in human leukemia cells. |
| Q28242990 | SLC19: the folate/thiamine transporter family |
| Q34205753 | SLC19A1 pharmacogenomics summary |
| Q50294829 | SLC19A1 transports 5-methyl-THF from extracellular region to cytosol |
| Q34469448 | Structural analysis of the human RFC-1 gene encoding a folate transporter reveals multiple promoters and alternatively spliced transcripts with 5' end heterogeneity |
| Q38354207 | Structural organization of the reduced folate carrier gene in Chinese hamster ovary cells |
| Q34657202 | Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter |
| Q34478826 | Structure and organization of the human reduced folate carrier gene |
| Q45173708 | Structure and regulation of the murine reduced folate carrier gene: identification of four noncoding exons and promoters and regulation by dietary folates |
| Q42495961 | The basal promoters for the human reduced folate carrier gene are regulated by a GC-box and a cAMP-response element/AP-1-like element. Basis for tissue-specific gene expression |
| Q37663377 | The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer |
| Q79340365 | The role of impaired transport in (pre)clinical resistance to methotrexate: insights on new antifolates |
| Q33541483 | Therapeutic strategies targeting proteins that regulate folate and reduced folate transport |
| Q28609909 | Topological and functional analysis of the human reduced folate carrier by hemagglutinin epitope insertion |
| Q42990934 | Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons |
| Q42471678 | Transcription of the mouse RFC-1 gene encoding a folate transporter. Multiplicity and properties of promoters with minimum requirements for their basal activity |
| Q37663396 | Uptake carriers and oncology drug safety |
| Q74308899 | Variable expression of RFC1 in human leukemia cell lines resistant to antifolates |
Search more.